Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 12Central Nervous System Neoplasms 11Glioblastoma 10Gliosarcoma 8Glioma 7Astrocytoma 4Oligodendroglioma 3Neuroblastoma 3Melanoma 3Medulloblastoma 3Sarcoma 2Recurrence 2Osteosarcoma 2Neuroectodermal Tumors, Primitive 2Neoplasms 2Ependymoma 2Wilms Tumor 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma, Kaposi 1Sarcoma, Ewing 1Salivary Gland Neoplasms 1Rhabdomyosarcoma 1Retinoblastoma 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pinealoma 1

Interventions

Bevacizumab 4Temozolomide 3Irinotecan 3Sorafenib 2pembrolizumab 1ibrutinib 1Vorinostat 1Valproic Acid 1Transcranial Magnetic Stimulation 1Therapeutics 1Thalidomide 1Surveys and Questionnaires 1Sildenafil Citrate 1Radiosurgery 1Pliability 1Palliative Care 1Lenalidomide 1Laparoscopy 1Exercise 1Equipment and Supplies 1Carboplatin 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurologic Manifestations × Thalidomide × CNS × Clear all
NCT00251797 2010-01-07

A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors

University of New Mexico

Phase 1 Completed
10 enrolled
CNS

Brain Neoplasms, Neoplasms, Neurologic Manifestations, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡